Table 1.

Baseline Characteristics of Patients Included in This Study

Characteristics		Number of patients	Percentage
Age	20-30	4	1.45
	31-40	33	13.82
	41-50	107	38.91
	51-60	65	23.64
	>60	61	22.18
SBR Grade	Grade 1	17	6.18
	Grade 2	152	55.27
	Grade 3	106	38.55
Presence of	Oui	130	47.27
emboli	Non	145	52.73
Tumor size	<1cm	36	13.09
	1-5cm	221	80.36
	5-10cm	2	0.73
	>10cm	16	5.82
RE%	Negative (<1%)	62	22.55
	Positive (>1%)	213	77.45
RE intensity	Intense	123	44.73
	Moderate	67	24.36
	Negative	85	30.91
RP%	Negative (<1%)	75	27.27
	Positive (>1%)	200	72.73
PR intensity	Intense	95	34.55
	Moderate	72	26.18
	Negative	108	39.27
HER2 SCORE	0+	133	48.36
	1+	62	22.55
	2+	25	9.09
	3+	55	20.00
KI-67%	High (>10%)	241	87.64
	Low (<10%)	34	12.36
T,n	pT1	174	63.27
	pT2	99	34.91
	pT3	2	0.73
N, n	pN0	154	56
	pN1	78	28.36
	pN2	31	11.27
	pN3	12	4.26
M, n	0	275	100
pStage	Stade I	117	42.55
	Stade II	114	41.46
	Stade III	43	15.63
	Stade IV	1	0.36